You are here: Industry Insights > Touchlight

News List

Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory PharmaSources
April 26, 2024
Biobatteries use enzymes to generate electricity from the breakdown of complex fuels, such as carbohydrates, fatty acids and alcohols.
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms PharmaSources
January 28, 2025
Touchlight, a pioneer in synthetic DNA technology, appoints Will Downie as an adviser to support the strategic growth of its synthetic DNA platforms.
Touchlight’s dbDNA™ Manufacturing Facility Receives World-First GMP License from MHRA PharmaSources
January 14, 2025
Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification.
AskBio, Touchlight Restructure Former JV, Touchlight AAV contractpharma
February 08, 2022
Both parties benefit from co-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA.
DNA production specialist Touchlight raises £42m pharmatimes
March 12, 2021
Hampton, UK-based biotech company Touchlight has raised £42m in its latest fundraising round, led by Bridford Investments Limited.
Touchlight Appoints CEO contractpharma
October 22, 2020
Karen will work to further expand the company's contract manufacturing business, which delivers GMP materials to third parties developing COVID-19 vaccines.